Source: Monash IVF Group
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Monash IVF Group (MVF) acquires PIVET Medical Centre, marking its foray into the Western Australian IVF services market
  • Monash IVF will pay an initial upfront cash consideration of $9.4 million, with the potential for additional earn out payments over a one to two year period
  • The company’s entry into a new domestic IVF market makes the acquisition strategically attractive
  • Completion is expected to occur during the first quarter of FY2023 and will be funded through Monash IVF’s operating cash flows and debt facilities available
  • Monash IVF shares are up 4.03 per cent, trading at $1.10 as of 1:03 pm AEST

Monash IVF Group (MVF) has acquired PIVET Medical Centre,marking its foray into the Western Australian IVF services market.

Monash IVF will pay an initial upfront cash consideration of $9.4 million on a debt free basis, with the potential for additional earn out payments over a one to two year period from completion.

The company’s entry into a new domestic IVF market makes the acquisition strategically attractive, as noted by Managing Director and CEO Michael Knaap.

“Monash IVF currently has no presence in the attractive Perth market and the acquisition provides further geographic diversification for Monash IVF as we continue to increase our clinical footprint across Australia and South East Asia,” Mr Knaap said.

In addition, the Cairns Fertility Centre business compliments the company’s existing IVF clinics in Northern Queensland.

PIVET generates approximately $8 million revenue per annum and is anticipated to increase net profit after tax (NPAT) by approximately four per cent.

Completion is expected to occur during the first quarter of FY2023 and is expected to be funded through Monash IVF’s operating cash flows and debt facilities available.

The company believes the growth of PIVET will come as a result of continued exceptional patient experience, investment in technology and infrastructure, and attraction of new fertility specialists.

The Perth-born business brings 9 fertility specialists which have worked together for several years, into the Monash IVF clinician network.

Monash IVF shares were up 4.03 per cent, trading at $1.10 as of 1:03 pm AEST.

MVF by the numbers
More From The Market Online

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…